department of otolaryngology

Stanford University School of Medicine’s Lloyd Minor, MD, center, spoke about health care in the era of precision medicine during his recent Flexner Discovery Lecture. Here, he poses with VUMC’s David Haynes, MD, left, and Ron Eavey, MD.
February 28, 2019

Precision health talk

Stanford University School of Medicine’s Lloyd Minor, MD, center, spoke about health care in the era of precision medicine during his recent Flexner Discovery Lecture.

Young Kim, MD, PhD, left, Michael Korrer, PhD, and colleagues are studying a potential new cancer immunotherapy option.
February 21, 2019

Discovery points to new cancer immunotherapy option

An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

February 14, 2019

Study aims to change standard of care for laryngeal paralysis

Vanderbilt University Medical Center’s David Zealear, PhD, has received a $3.6 million grant from the National Institutes of Health (NIH) for a clinical trial to study the effectiveness of bilateral laryngeal pacing in treating patients with a bilaterally paralyzed larynx.

February 14, 2019

Stanford’s Minor set for Feb. 21 Discovery Lecture

Lloyd Minor, MD, the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, will discuss “Digitally Driven: Health Care in the Era of Precision Health,” during a Flexner Discovery Lecture on Thusday, Feb. 21.

January 17, 2019

Study finds unique form of chronic sinusitis in older patients

Older patients with a diagnosis of chronic sinusitis — a disease of the nasal cavity and paranasal sinuses that often persists over many years — have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

November 15, 2018

Surgeon helps restore cancer patients’ functionality

Sarah Rohde long had an interest in treating cancer, and her research during her undergraduate and medical school years at the University of Virginia underscored that. What she didn’t expect was to become a surgeon.